Cachexia in cancer: what is in the definition?

Area of Science:

• Oncology
• Gerontology
• Clinical Nutrition

Background:

• Cancer cachexia significantly impacts patient prognosis and quality of life.
• Accurate diagnostic criteria for cancer cachexia are crucial for effective management and treatment.
• Existing definitions vary in their emphasis on specific clinical and biochemical parameters.

Purpose of the Study:

• To compare the diagnostic accuracy and prognostic value of two distinct cancer cachexia definitions.
• To provide evidence-based guidance for the diagnosis of cancer cachexia.
• To evaluate the impact of different diagnostic criteria on overall survival (OS) rates.

Main Methods:

• A cohort of 167 cancer patients was assessed over five visits (baseline and every 3 months).
• Clinical data, including muscle strength, nutritional status, and psychosocial factors, were collected.
• Two definitions of cachexia (Fearon et al. and Evans et al.) were applied, and mean OS rates were compared between cachectic and non-cachectic groups for each definition.

Main Results:

• 70% of patients met the Fearon et al. criteria for cachexia, versus 40% using the Evans et al. criteria.
• The mean OS was 0.97 years for cachectic patients by Fearon et al. and 0.55 years by Evans et al.
• The Evans et al. definition demonstrated a more significant difference in OS between cachectic and non-cachectic patients, indicating greater prognostic value.

Conclusions:

• The Evans et al. definition, which includes factors like abnormal biochemistry, fatigue, and anorexia alongside sarcopenia, is a more effective tool for diagnosing cancer cachexia.
• While weight loss and BMI decline are important, other factors are more decisive in predicting survival in cancer patients.
• A comprehensive assessment incorporating inflammation, anemia, fatigue, and reduced food intake is essential for accurate cachexia diagnosis and prognosis.